<--- Back to Details
First PageDocument Content
Risk management / Safety engineering / National Industrial Chemicals Notification and Assessment Scheme / Occupational safety and health / Therapeutic Goods Administration / Good laboratory practice / Food and Drug Administration / Patient safety / Regulatory risk differentiation / Good manufacturing practice / Risk assessment / Health insurance
Date: 2016-03-10 18:29:52
Risk management
Safety engineering
National Industrial Chemicals Notification and Assessment Scheme
Occupational safety and health
Therapeutic Goods Administration
Good laboratory practice
Food and Drug Administration
Patient safety
Regulatory risk differentiation
Good manufacturing practice
Risk assessment
Health insurance

Appendix B.10 Department of Health Summary Health reported 59 measures during the year, with a total net regulatory saving of $96.8 million per year. In 2015, the Health Portfolio continued to contribute strongly to th

Add to Reading List

Source URL: www.cuttingredtape.gov.au

Download Document from Source Website

File Size: 41,57 KB

Share Document on Facebook

Similar Documents

TAMU Laboratory Safety Manual  TEXAS A&M UNIVERSITY LABORATORY SAFETY MANUAL

TAMU Laboratory Safety Manual TEXAS A&M UNIVERSITY LABORATORY SAFETY MANUAL

DocID: 1riAL - View Document

The Agency for Medicinal Products and Medical Devices of the Republic of Slovenia has prepared the unofficial consolidated text for the Medicinal Products Act which includes:  Medicinal Products Act (Official Gazette

The Agency for Medicinal Products and Medical Devices of the Republic of Slovenia has prepared the unofficial consolidated text for the Medicinal Products Act which includes:  Medicinal Products Act (Official Gazette

DocID: 1r1yj - View Document

ASTRAZENECA GLOBAL POLICY  QUALITY AND REGULATORY COMPLIANCE  WHO IS THIS POLICY FOR?

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE WHO IS THIS POLICY FOR?

DocID: 1qdzU - View Document

Code of Practice for the Promotion of Animal Medicines Together with the Rules of Procedure for the

Code of Practice for the Promotion of Animal Medicines Together with the Rules of Procedure for the

DocID: 1q2Fu - View Document

IRIS PHARMA FACT SHEET A GLOBAL SERVICE PROVIDER OF PRECLINICAL AND CLINICAL RESEARCH IN OPHTHALMOLOGY KEY FACTS  COMPANY OVERVIEW

IRIS PHARMA FACT SHEET A GLOBAL SERVICE PROVIDER OF PRECLINICAL AND CLINICAL RESEARCH IN OPHTHALMOLOGY KEY FACTS COMPANY OVERVIEW

DocID: 1pBzr - View Document